SIRT6 and liver cancer: In liver cancer, upregulation of SIRT6 is very common in liver cancer tissues and is highly correlated with poor overall survival rate, disease-free survival, hepatocellular carcinoma (HCC) cell migration, tumor size, tumor grade, and vascular invasion (116, 117).